The effect of vitamin E or vitamin A on the prevention of renal scarring in children with acute pyelonephritis

Pediatr Nephrol. 2013 Feb;28(2):277-83. doi: 10.1007/s00467-012-2308-4. Epub 2012 Oct 7.

Abstract

Background: Numerous factors may contribute to renal tissue injury after urinary tract infection. We have evaluated the effects of vitamins A or E supplementation in combination with antibiotics for the prevention of renal scarring in acute pyelonephritis.

Methods: A simple non-blind randomized clinical trial was conducted on 61 children aged 1 month to 10 years between 2004 and 2006. The inclusion criteria were positive urine culture, clinical findings, and 99mTc-dimercaptosuccinic acid (DMSA) scintigraphy-based evidence in favor of acute pyelonephritis. The children were randomized into three treatment groups: 10-day treatment with only antibiotics (control group; n = 25) and 10-day treatment with supplements of vitamin A (n = 17) or vitamin E (n = 18) in addition to antibiotics during the acute phase of infection. The final analysis was performed after excluding male patients. Each patient was evaluated twice by 99mTc-DMSA scintigraphy performed at least 6 months apart. P < 0.05 was considered to be statistically significant.

Results: The analysis included 108 kidney units. The frequency of inflammation at the beginning of therapy was not significantly different in the three groups (63.3 % in vitamin A, 61 % in vitamin E, and 76.2 % in the control group). A worsening of lesions, based on the second 99mTc-DMSA scan, was observed in 42.5, 0, and 23.3 % of the control, vitamin E, and vitamin A patients, respectively (LR = 26.3, P < 0.001).

Conclusion: Vitamins A or E supplements were effective in reducing renal scarring secondary to acute pyelonephritis.

Publication types

  • Randomized Controlled Trial

MeSH terms

  • Anti-Bacterial Agents / therapeutic use
  • Antioxidants / therapeutic use*
  • Child
  • Child, Preschool
  • Cicatrix / diagnostic imaging
  • Cicatrix / etiology
  • Cicatrix / prevention & control*
  • Dietary Supplements*
  • Female
  • Humans
  • Infant
  • Infant, Newborn
  • Kidney / pathology
  • Pyelonephritis / complications*
  • Radionuclide Imaging
  • Radiopharmaceuticals
  • Technetium Tc 99m Dimercaptosuccinic Acid
  • Vitamin A / therapeutic use*
  • Vitamin E / therapeutic use*

Substances

  • Anti-Bacterial Agents
  • Antioxidants
  • Radiopharmaceuticals
  • Vitamin A
  • Vitamin E
  • Technetium Tc 99m Dimercaptosuccinic Acid